Companies / Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

NYSE: PTHSCIK 1919246DURHAM, NC
Insider flow · last 90 daysNet buys $1000.0K

Financials · FY2025

Revenue$16.80M
Net income$-43.32M
Total debt—
Cash$24.19M
Diluted EPS$-23.04
Shares outstanding3.8M

Ownership

3.8M shares outstanding · as of Aug 10, 2026
2.6%Insiders
Ownership
Insiders2.63%100,515
Institutions32.69%1,251,679
Public float64.68%2,476,275

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insider% of sharesShares
Davis Todd CDirector
1.98%75,834
0.64%24,681

Institutional holders 18

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
AIGH Capital Management LLC
13F manager
NewCommon Stock$9.30M+329K
329,098
8.60% of shares
medium
Q4 2025
as of
Cantor Fitzgerald, L. P.
13F manager
NewCommon Stock$1.08M+35K
34,990
0.91% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
ExitCommon Stock$-342.8K-11K
-100.00%
0
low
Q2 2026
as of
State Street Corporation
13F manager
NewCommon Stock$276.9K+10K
9,800
0.26% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
NewCommon Stock$150.5K+5K
5,324
0.14% of shares
low
Q1 2026
as of
Cantor Fitzgerald, L. P.
13F manager
AddCommon Stock$135.2K+6K
+18.39%
41,423
1.08% of shares
low
Q4 2025
as of
Persistent Asset Partners Ltd
13F manager
AddCommon Stock$111.7K+4K
+149.98%
6,007
0.16% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$35.0K+2K
+12.22%
15,290
0.40% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Ikarian Capital, LLCPassive13G/A———
3i, LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PTHSCommon StockEquity171126204BBG01C9YP5V5